EBV latency proteins are crucially recognized by T cells, with 1-2% of these cells targeting the virus throughout life. Primary infections in older individuals can lead to mononucleosis due to an overwhelming T cell response that fails to effectively target infected B cells. The potential for a vaccine to prepare the immune system for future infections could be a game-changer in preventing mono and its related complications.
